Cost-Effectiveness of a Single Inhaler Triple Therapy vs a Dual Inhaled Corticosteroid Plus Long-Acting Beta Agonist (ICS/LABA) for Patients with Chronic Obstructive Pulmonary Disease (COPD) in the United Kingdom (UK)
Abstract
Authors
E Fenwick AA Martin M Schroeder D Vetrini S Mealing N Risebrough O Solanke A Ismaila